V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007800 | 290005020 | 1.82 | 0 | Curative (C) | 2013-08-30 | 2013-08-30 | EVEROLIMUS | 2 | N | 290020212 | CARBOPLATIN |
| 290007801 | 290005023 | 1.62 | 77 | Palliative (P) | null | 2015-01-31 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020225 | CAPECITABINE |
| 290007802 | 290005023 | 1.6 | 51.5 | Adjuvant (A) | 2019-06-25 | 2019-07-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020225 | CAPECITABINE |
| 290007803 | 290005025 | 1.71 | 77.2 | Palliative (P) | 2014-10-05 | 2014-10-21 | Irinotecan | 2 | N | 290020248 | CAPECITABINE |
| 290007804 | 290005027 | 0 | null | Palliative (P) | 2017-10-05 | 2017-10-21 | Ralitrexed | N | null | 290020264 | DOXORUBICIN + OLARATUMAB |
| 290007805 | 290005028 | 1.79 | null | Adjuvant (A) | 2019-03-09 | 2019-03-21 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 290020268 | CAPECITABINE + OXALIPLATIN |
| 290007806 | 290005031 | 1.55 | null | Palliative (P) | 2017-06-07 | 2017-11-20 | Cisplatin | N | Y | 290020281 | CETUXIMAB + IRINOTECAN + MDG |
| 290007807 | 290007119 | 1.76 | 55.4 | Curative (C) | 2017-08-08 | 2017-08-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 290020320 | CAPECITABINE + MITOMYCIN |
| 290007808 | 290005038 | 1.62 | 76.8 | Palliative (P) | 2017-10-28 | 2018-01-03 | Sunitinib | 02 | N | 290020330 | ERLOTINIB |
| 290007809 | 290005039 | 0 | 83 | Adjuvant (A) | 2013-05-14 | 2013-05-14 | LANREOTIDE | N | N | 290020345 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 290007810 | 290005040 | 1.77 | 69.8 | Palliative (P) | 2019-04-14 | 2019-04-14 | CARBOPLATIN + RT | 02 | null | 290020347 | NOT MATCHED |
| 290007811 | 290005043 | 1.55 | 99 | Adjuvant (A) | 2017-04-29 | 2017-05-20 | Capecitabine + Mitomycin | N | N | 290020351 | CAPECITABINE + OXALIPLATIN |
| 290007812 | 290005046 | 1.76 | 111 | Curative (C) | 2017-02-23 | 2017-03-13 | CETUXIMAB + IRINOTECAN + MDG | N | N | 290020355 | CETUXIMAB + CISPLATIN + FU |
| 290007813 | 290005049 | null | 52.6 | Curative (C) | 2018-10-05 | 2018-11-09 | CAV | N | null | 290020367 | ESHAP |
| 290007814 | 290005052 | 1.87 | null | Curative (C) | 2018-12-19 | 2018-12-24 | OXALIPLATIN + MDG + PANITUMUMAB | N | null | 290020378 | CETUXIMAB + CISPLATIN + FU |
| 290007815 | 290005059 | null | 75 | Adjuvant (A) | 2014-06-14 | 2014-06-14 | Cisplatin + Radiotherapy | 02 | N | 290020389 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 290007816 | 290005060 | 1.7 | 80.8 | Palliative (P) | 2016-09-29 | 2016-12-16 | LANREOTIDE | 02 | N | 290020394 | ECX |
| 290007817 | 290005063 | 1.6 | null | Palliative (P) | null | 2015-12-07 | Cisplatin + Docetaxel +Fluorouracil | null | null | 290020400 | CAPECITABINE |
| 290007818 | 290005067 | 1.65 | null | Palliative (P) | 2016-10-05 | 2016-10-05 | CARBOPLATIN + RT | N | N | 290020421 | CAPECITABINE |
| 290007819 | 290005069 | null | 57.4 | Palliative (P) | 2017-06-19 | 2017-06-21 | Doxorubicin + Olaratumab | N | N | 290020425 | CETUXIMAB |
| 290007820 | 290005075 | null | null | Curative (C) | 2015-09-17 | 2015-09-17 | Trastuzumab Subcutaneous | N | null | 290020449 | CARBOPLATIN |
| 290007821 | 290005079 | 1.71 | 50 | Adjuvant (A) | 2015-11-09 | 2017-01-14 | Cisplatin + Radiotherapy | N | N | 290020475 | TRASTUZUMAB |
| 290007822 | 290005080 | 0 | 66.3 | Curative (C) | null | 2017-07-26 | Capecitabine + Cisplatin | N | N | 290020492 | COMPARE TRIAL |
| 290007823 | 290005081 | 1.87 | 50.3 | Palliative (P) | 2012-11-06 | 2014-11-08 | CARBOPLATIN + VINORELBINE | 02 | N | 290020503 | INTERAACT TRIAL |
| 290007824 | 290005082 | null | null | Curative (C) | 2016-04-22 | 2016-09-19 | CARBOPLATIN + RT | N | null | 290020514 | CAPECITABINE + CARBOPLATIN |
| 290007825 | 290005088 | 1.76 | null | Palliative (P) | null | 2017-01-01 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 290020542 | EOX |
| 290007826 | 290005089 | 1.6 | null | Curative (C) | 2016-12-22 | 2017-04-17 | CAPECITABINE + MITOMYCIN + RT | null | null | 290020545 | BALLAD TRIAL |
| 290007827 | 290005096 | 1.74 | null | Palliative (P) | 2016-10-09 | 2016-12-03 | LANREOTIDE | 2 | N | 290020575 | CETUXIMAB |
| 290007828 | 290005098 | 1.65 | 0 | Adjuvant (A) | 2018-08-17 | 2018-09-01 | Trastuzumab Subcutaneous | 2 | N | 290020576 | DOCETAXEL |
| 290007829 | 290005102 | 1.67 | 65.9 | Adjuvant (A) | 2017-02-13 | 2017-02-27 | Capecitabine + Oxaliplatin 21day | N | N | 290020596 | CAPECITABINE + OXALIPLATIN |
| 290007830 | 290005108 | null | 72.7 | Adjuvant (A) | 2018-03-10 | 2018-03-12 | Cisplatin 100 + RT(H&N) 1 day | N | null | 290020608 | CAPECITABINE |
| 290007831 | 290005110 | null | 56 | Palliative (P) | 2017-03-06 | 2017-03-06 | LANREOTIDE | 02 | N | 290020614 | NOT MATCHED |
| 290007832 | 290007150 | null | 43.9 | Palliative (P) | 2018-12-11 | 2018-12-18 | Pazopanib | N | null | 290020614 | CAPECITABINE |
| 290007833 | 290005113 | 1.65 | 42.1 | Palliative (P) | 2017-11-25 | 2018-03-12 | Cetuximab 7 day (Cycle 1) | 02 | N | 290020635 | EOX |
| 290007834 | 290005117 | 1.53 | 88.9 | Adjuvant (A) | null | 2017-07-18 | FLUOROURACIL + MITOMYCIN | N | N | 290020638 | CETUXIMAB + RT |
| 290007835 | 290005120 | null | 130.6 | Palliative (P) | 2017-12-15 | 2017-12-15 | Irinotecan | N | N | 290020647 | TRIAL |
| 290007836 | 290007154 | null | 0 | Palliative (P) | 2015-11-15 | 2015-11-15 | MCX | 02 | N | 290020655 | CARBOPLATIN + DACARBAZINE |
| 290007837 | 290005124 | null | 95.7 | Palliative (P) | 2017-03-06 | 2017-03-19 | Enzalutamide | 02 | N | 290020664 | REGORAFENIB |
| 290007838 | 290007978 | 1.73 | 60 | null | 2018-04-30 | 2018-05-13 | CARBOPLATIN + RT | 2 | N | 290020677 | OXALIPLATIN + RALTITREXED |
| 290007839 | 290005129 | 1.61 | 74 | Curative (C) | 2015-02-06 | 2015-02-06 | Capecitabine + Oxaliplatin 21day | N | Y | 290020680 | CAPECITABINE + OXALIPLATIN |
| 290007840 | 290005131 | 1.88 | 61.6 | Palliative (P) | 2013-11-22 | 2014-08-14 | Capecitabine | 02 | N | 290020688 | CARBOPLATIN + PACLITAXEL |
| 290007841 | 290005133 | 1.65 | 83.7 | Neo-adjuvant (N) | 2015-04-28 | 2015-05-10 | Capecitabine + Oxaliplatin 21day | 2 | N | 290020691 | OXALIPLATIN + MDG + PANITUMUMAB |
| 290007842 | 290005135 | null | 84.3 | Palliative (P) | 2016-12-26 | 2017-02-08 | Cisplatin + Radiotherapy | N | N | 290020706 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 290007843 | 290005137 | 1.6 | 94.2 | Curative (C) | 2017-12-01 | 2017-12-05 | Cisplatin | 02 | N | 290020708 | METHOTREXATE INTRATHECAL |
| 290007844 | 290005138 | 1.66 | 0 | Curative (C) | 2014-07-26 | 2014-08-02 | OCTREOTIDE | N | N | 290020709 | CAPECITABINE + RT |
| 290007845 | 290008458 | 1.68 | 75.5 | Curative (C) | 2018-04-16 | 2018-04-20 | Ipilimumab | 02 | N | 290020726 | CAPECITABINE + MITOMYCIN + RT |
| 290007846 | 290008458 | 1.56 | 98 | Curative (C) | 2014-11-27 | 2016-01-13 | CAPECITABINE + OXALIPLATIN | 1 | N | 290020726 | TRIAL |
| 290007847 | 290005145 | 1.74 | 50.4 | Curative (C) | 2016-11-06 | 2016-11-13 | Docetaxel 75mg/m2 (21 day) | N | Y | 290020758 | CARBOPLATIN + RT |
| 290007848 | 290007166 | 0 | 66.2 | null | 2017-12-03 | 2017-12-15 | Capecitabine + Cisplatin | 02 | N | 290020761 | LANREOTIDE |
| 290007849 | 290005147 | 1.67 | null | Palliative (P) | null | 2019-01-12 | CARBOPLATIN | N | null | 290020764 | PANITUMUMAB |